FDA Logo links to FDA home page
Center for Biologics Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Biologics Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

horizonal rule
CBER links to product areas
CBER links
horizonal rule

CBER Index

horizonal rule

A to C | D to F | G to I | J to M | N to P | Q to S | T to Z

Nabi-HB (Hepatitis B Immune Globulin (Human )
     3/24/1999 Application
     10/23/2001 Application

NDA Product Approval Information

Notice of Initiation of Disqualification Proceedings Letters

Notification Process for Transfusion Related Fatalities and Donation Related Deaths

NovoSeven (Coagulation Factor VIIa (Recombinant)

OCTAGAM (Immune Globulin Intravenous (Human))

Ombudsman

OraQuick ADVANCE Rapid HIV-1/2 Antibody Test
      6/22/2004 Supplement
      3/26/2004 Supplement
      3/19/2004 Supplement

OraQuick Rapid HIV-1 Antibody Test
      11/7/2002 Application
      9/5/2003 Supplement

PACIS (BCG, Live)

PAKAUTO Platelet Antibody Screening Test

Pediarix (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined)

Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein)(Prevnar)
      2/17/2000 Application
      10/01/2002 Supplement

Pooled Plasma, Solvent Detergent Treated (VIPLAS/SD, PLAS+SD)

Postmarketing: Report to Congress: Reports on Postmarketing Studies [FDAMA 130]

Postmarketing Study Commitments

Prescription Drug Marketing Act - (PDMA)

Prescription Drug User Fee Act - (PDUFA)

Prescription Drug User Fee Act (PDUFA) - Billable Products

Premarket Approval - Devices -Approval Information

Presentations / Summaries from Meetings

Prevnar (Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein)
      2/17/2000 Application
      10/01/2002 Supplement

Procleix (Human Immunodeficiency Virus-1 / Hepatitis C Virus Assay (HIV-1/HCV))
      2/27/2002 Application
      6/4/2004 Supplement

Product Deviation Reporting

Product Information

Product Labeling

Product Shortage Information

Products and Establishments, Licensed

Products - Transfer of Therapeutic Products to CDER

Proposed / Final Rules

Publications

Public Inquiries

 

 
horizonal rule